Does THIOTEPA Cause Post transplant lymphoproliferative disorder? 68 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 68 reports of Post transplant lymphoproliferative disorder have been filed in association with THIOTEPA (Thiotepa). This represents 1.0% of all adverse event reports for THIOTEPA.
68
Reports of Post transplant lymphoproliferative disorder with THIOTEPA
1.0%
of all THIOTEPA reports
26
Deaths
7
Hospitalizations
How Dangerous Is Post transplant lymphoproliferative disorder From THIOTEPA?
Of the 68 reports, 26 (38.2%) resulted in death, 7 (10.3%) required hospitalization, and 1 (1.5%) were considered life-threatening.
Is Post transplant lymphoproliferative disorder Listed in the Official Label?
Yes, Post transplant lymphoproliferative disorder is listed as a known adverse reaction in the official FDA drug label for THIOTEPA.
What Other Side Effects Does THIOTEPA Cause?
Off label use (762)
Febrile neutropenia (645)
Mucosal inflammation (616)
Cytomegalovirus infection (446)
Product use in unapproved indication (425)
Pyrexia (359)
Drug ineffective (358)
Acute graft versus host disease in skin (355)
Acute graft versus host disease (331)
Cytomegalovirus infection reactivation (325)
What Other Drugs Cause Post transplant lymphoproliferative disorder?
TACROLIMUS (2,529)
MYCOPHENOLATE MOFETIL (1,762)
PREDNISONE (1,441)
CYCLOSPORINE (957)
PREDNISOLONE (772)
RITUXIMAB (719)
CYCLOPHOSPHAMIDE (667)
METHYLPREDNISOLONE (506)
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (439)
MYCOPHENOLIC ACID (438)
Which THIOTEPA Alternatives Have Lower Post transplant lymphoproliferative disorder Risk?
THIOTEPA vs THIOTHIXENE
THIOTEPA vs THROMBIN
THIOTEPA vs THROMBIN HUMAN
THIOTEPA vs THYMOCYTE IMMUNE GLOBULIN NOS
THIOTEPA vs THYMOGLOBULINE